PCV5 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with No Treatment Under the Brazilian Private Health Care System Per ...
Abstract
Authors
A. Schiola A.P. Silva N.B. Santoni L. Paladini V. Teich C. Pepe M.M. Rocha